1.
The Effects of Extracellular K～+ and Mg～(2+) Concentrations on Drug-induced Vasoactive Reactions;
胞外K～+和Mg～（2+）浓度对血管活性药物作用的影响
2.
Observation of Vasoactive Agent in Management of Patients with Hepatorenal Syndrome
血管活性药物治疗肝肾综合征的疗效分析
3.
Applications of vasoactive agents in neonates with shock
血管活性药物在新生儿休克治疗中的应用
4.
Effect of vasoactive agents on acute lung injury induced by hydrochloric acid in rats
血管活性药物对盐酸吸入性肺损伤大鼠动脉血氧分压的影响
5.
The Experimental Study of the Effect of Competitive Flow and Vasoactive Drugs on Arterial and Veinal Grafts Flow after Coronary Artery Bypass Grafting;
CABG术后竞争血流与血管活性药物对动脉桥、静脉桥血流影响的实验研究
6.
Some drugs acre used before or after operation for improvement of microcirculation.
早期行局部减张术，术前、术后采用小分子右旋糖酐及血管活性药物处理。
7.
Results:Anisodanine,as an active medicine for blood vessels,rece ives such as strenthening the curative effects and increasing the cure rate.
结果山莨菪碱作为血管活性药物,收到了加强疗效,提高治愈率的成效。
8.
Experimental Investigates of Vasoactivating Agents Change the Renal Aquaporins Expression after Common Bile Duct Recanalization;
血管活性药物对胆道梗阻—再通术后肾水通道蛋白表达影响的实验研究
9.
The effects of different anesthetic on nasal mucosal blood flow and plasma concentration of vasoactive intestinal polypeptide
不同麻醉药物对鼻黏膜血流及血浆血管活性肠肽水平的影响
10.
Research on Inhibition of Traditional Chinese Medicine Extracts and Active Fraction on Angiotensin Converting Enzyme
中药提取物及活性部位抑制血管紧张素转化酶活性的研究
11.
Pharmacological Studies of Endogenous and Exogenous Vasoactive Agents on Coronary Artery;
作用于冠状动脉的外（内）源血管活性物质的药理作用研究
12.
Design,Synthesis and Cerebrocardiac Vascular Pharmacological Activity Studies of the Novel Ligustrazine Derivatives;
川芎嗪衍生物的设计、合成及其心脑血管药理活性研究
13.
Antiplatelet therapy for ischemic cerebrovascular diseases
抗血小板药物治疗缺血性脑血管病的合理应用
14.
Blood vessel active material and cardiovascular disease patient's relevant analysis
血管活性物质与心血管疾病患者的相关性分析
15.
Studies on the Chemical Modifications of Endostatin and the Bioactivities and Pharmacokinetics of the Modified Derivatives
新生血管生成抑制剂内皮抑素的化学修饰及修饰物的生物活性和药代动力学研究
16.
Pathogenesis of Ischemic Cerebrovascular Disease and the Related Therapeutic Drug
缺血性脑血管疾病的发病机制及治疗药物
17.
New theory and new practice of Statins in the management of ischemic stroke
他汀类药物治疗缺血性脑血管病新理论与实践
18.
These drugs reduce blood pressure by blocking an enzyme that converts angiotensin to an active form that constricts blood vessels.
这些药物通过拦阻激活血管紧张肽的酶降低血压。血管紧张肽造成血管收缩。